*8 persons missing data on region of residence excluded. HR = Hazard ratio. †Age, coronary heart disease, rheumatoid arthritis, use of anti-diabetics, and hormone replacement therapy at cohort entry i
To investigate the effects of Zongertinib, a HER2 inhibitor on different cell lines and under various conditions, we used expression data from dedicated biomarker in vivo and in vitro studies. Overall
